![Geoff Oxnard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Geoff Oxnard
Chief Tech/Sci/R&D Officer at
BLOSSOMHILL THERAPEUTICS, INC.
Net worth: 277 446 $ as of 30/06/2026
Profile
Geoff Oxnard currently works at Blossomhill Therapeutics, Inc., as Chief Medical Officer & Executive Vice President from 2025.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 06/08/2026 | 17,785 ( 0.08% ) | 277 446 $ | 30/06/2026 |
Geoff Oxnard active positions
| Companies | Position | Start |
|---|---|---|
| BLOSSOMHILL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2025 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
13
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Geoff Oxnard
